Combination of activated Schwann cells with bone mesenchymal stem cells: The best cell strategy for repair after spinal cord injury in rats

Regenerative Medicine

Volumn 6, Issue 6, 2011, Pages 707-720

  Ban, De Xiang ^a   Ning, Guang Zhi ^a   Feng, Shi Qing ^a   Wang, Ying ^a   Zhou, Xian Hu ^a   Liu, Yang ^a   Chen, Jia Tong ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Activated Schwann cells; Basso; Beattie; bone mesenchymal stem cells; Bresnahan score; corticospinal tract; footprint analysis; spinal cord injury

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL ORGANELLE; CELL POPULATION; CELL THERAPY; CELL TRANSPLANTATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MESENCHYMAL STEM CELL; MYELIN SHEATH; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SCHWANN CELL; SPINAL CORD INJURY;

ANIMALS; AXONS; BIOTINYLATION; BONE AND BONES; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MOTOR ACTIVITY; RATS; RATS, WISTAR; SCHWANN CELLS; SPINAL CORD INJURIES; WOUND HEALING;

EID: 82955170628     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.32     Document Type: Article

References (41)

1. Siebert JR, Middleton FA, Stelzner DJ. Long descending cervical propriospinal neurons differ from thoracic propriospinal neurons in response to low thoracic spinal injury. BMC Neurosci. 11, 148-151 (2010)
2. Pimentel L, Diegelmann L. Evaluation and management of acute cervical spine trauma. Emerg. Med. Clin. North Am. 28, 719-738 (2010)
3. Schwab ME, Caroni P. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 60, 404-405 (2008)
4. Kenefick RW. Energy cost of physical activities in persons with spinal cord injury-comment. Med. Sci. Sports Exerc. 42, 689-690 (2010).
5. Deng XY, Zhou RP, Lu KW, Jin DD. Lithium chloride combined with human umbilical cord blood mesenchymal stem cell transplantation for treatment of spinal cord injury in rats. Nan. Fang Yi Ke Da Xue Xue Bao 30, 2436-2439 (2010).
6. Yague JG, Foffani G, Aguilar J. Cortical hyperexcitability in response to preserved spinothalamic inputs immediately after spinal cord hemisection. Exp. Neurol. 17, 343-347 (2010)
7. van Hedel HJ, Rudhe C. Motor recovery after spinal cord injury: Assessments, factors and mechanisms. Praxis 99, 963-970 (2010)
8. Lynskey JV, Sandhu FA, Dai HN et al. Delayed intervention with transplants and neurotrophic factors supports recovery of forelimb function after cervical spinal cord injury in adult rats. J. Neurotrauma 23, 617-634 (2006) (Pubitemid 43728051)
9. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Morshead CM, Fehlings MG. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J. Neurosci. 26, 3377-3389 (2006)
10. Mishra PJ, Mishra PJ, Glod JW, Banerjee D. Mesenchymal stem cells: Flip side of the coin. Cancer Res. 69, 1255-1258 (2009)
11. Lindner U, Kramer J, Rohwedel J, Schlenke P. Mesenchymal stem or stromal cells: Toward a better understanding of their biology? Transfus. Med. Hemother. 37, 75-83 (2010)
12. Ripa RS, Haack-Sørensen M, Wang Y et al. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: Results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation 116, 124-130 (2007)
13. Chen SL, Fang WW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94, 92-95 (2004) (Pubitemid 38813459)
14. Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin. Pharmacol. Ther. 83, 723-730 (2008) (Pubitemid 351556019)
15. Bouchez G, Sensebe L, Vourch P et al. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem. Int. 52, 1332-1342 (2008)
16. Verrier JD, Semple-Rowland S, Madorsky I, Papin JE, Notterpek L. Reduction of Dicer impairs Schwann cell differentiation and myelination. J. Neurosci. Res. 88, 2558-2568 (2010).
17. Rossi SL, Nistor G, Wyatt T et al. Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord. PLoS ONE 5, e11852 (2010)
18. Wu B, Ren X. Promoting axonal myelination for improving neurological recovery in spinal cord injury. J. Neurotrauma 26, 1847-1856 (2009)
19. Geuna S, Fornaro M, Raimondo S, Giacobini-Robecchi MG. Plasticity and regeneration in the peripheral nervous system. Ital. J. Anat. Embryol. 115, 91-94 (2010)
20. Siemionow M, Demir Y, Mukherjee AL. Repair of peripheral nerve defects with epineural sheath grafts. Ann. Plast. Surg. 65, 546-554 (2010)
21. Bravin M, Savio T, Strata P, Rossi F. Olivocerebellar axon regeneration and target reinnervation following dissociated Schwann cell grafts in surgically injured cerebella of adult rats. Eur. J. Neurosci. 9, 2634-2649 (1997) (Pubitemid 28082953)
22. Sayers ST, Khan N, Ahmed Y, Shahid R, Khan T. Preparation of brain-derived neurotrophic factor- and neurotrophin-3-secreting Schwann cells by infection with a retroviral vector. J. Mol. Neurosci. 10, 143-160 (1998) (Pubitemid 28350117)
23. Yan J, Nunn AD, Thomas R. Selective induction of cell adhesion molecules by proinflammatory mediators in human cardiac microvascular endothelial cells in culture. Int. J. Clin. Exp. Med. 3, 315-331 (2010)
24. Siesser PF, Maness PF. Erratum to: L1 cell adhesion molecules as regulators of tumor cell invasiveness. Cell Adh. Migr. 4, 635-640 (2010).
25. Feng SQ, Kong XH, Guo SF,Wang P, Li L, Zhong JH, Zhou XF. Treatment of spinal cord injury with co-grafts of genetically modified Schwann cells and fetal spinal cord cell suspension in the rat. Neurotox. Res. 7, 169-177 (2005)
26. Feng SQ, Zhou XF, Rush RA, Ferguson IA. Graft of pre-injured sural nerve promotes regeneration of corticospinal tract and functional recovery in rats with chronic spinal cord injury. Brain Res. 12, 40-48 (2008).
27. Ban DX, Kong XH, Feng SQ, Ning GZ, Chen JT, Guo SF. Intraspinal cord graft of autologous activated Schwann cells efficiently promotes axonal regeneration and functional recovery after rat's spinal cord injury. Brain Res. 1256, 149-161 (2009).
28. Sbai O, Devi TS, Melone MA et al. RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion. J. Cell Sci. 123(Pt 24), 4332-4339 (2010)
29. Maurel P, Salzer JL. Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity. J. Neurosci. 20, 4635-4645 (2000) (Pubitemid 30396629)
30. Svaren J, Meijer D. The molecular machinery of myelin gene transcription in Schwann cells. Glia 56, 1541-1551 (2008)
31. Woodhoo A, Sommer L. Development of the Schwann cell lineage: From the neural crest to the myelinated nerve. Glia 56, 1481-1490 (2008)
32. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726-736 (2008)
33. Mishra PJ, Mishra PJ, Humeniuk R et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 68, 4331-4339 (2008)
34. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999) (Pubitemid 29282067)
35. Chopp M, Li Y. Transplantation of bone marrow stromal cells for treatment of central nervous system diseases. Adv. Exp. Med. Biol. 585, 49-64 (2006)
36. Chen JR, Cheng GY, Sheu CC, Tseng GF, Wang TJ, Huang YS. Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral stroke. J. Anat. 213, 249-258 (2008).
37. Harvey RL, Chopp M. The therapeutic effects of cellular therapy for functional recovery after brain injury. Phys. Med. Rehabil. Clin. N. Am. 14, 143-151(2003)
38. Deng Y, Liu Y, Zhu W, Bi X, Wang Y, Ye M, Zhou GQ. The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy 2, 1-14 (2008)
39. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-12 (1995)
40. Metz GA, Merkler D, Dietz V, Schwab ME, Fouad K. Efficient testing of motor function in spinal cord injured rats. Brain Res. 883, 165-177 (2000)
41. de Medinaceli L, Freed WJ, Wyatt RJ. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp. Neurol. 77, 634-643 (1982). (Pubitemid 12011176)